Home LiteratureArticle Details
PMID: 15830478 Published · ppublish English Journal Article

Antimicrobial susceptibilities of anaerobic bacteria: recent clinical isolates.

Antimicrobial agents and chemotherapy ·Vol. 6 ·No. 3 ·1974-09-00 ·Pages 311-5

Staneck JL, Washington JA

Abstract

Minimal inhibitory concentrations of clindamycin, minocycline, metronidazole, penicillin, and carbenicillin were determined by agar dilution against 150 recent clinical isolates of anaerobic bacteria. Ninety-nine percent of Bacteroides fragilis and all B. melaninogenicus, Clostridium perfringens, and Fusobacterium were inhibited by clindamycin at 3.1 mug/ml. Only 58% of other clostridial species were inhibited by this concentration of clindamycin. Minocycline at 3.1 mug/ml inhibited 72% of C. perfringens, 81% of other Clostridium species, and 66, 75, and 100% of B. fragilis, B. melaninogenicus, and Fusobacterium, respectively. Metronidazole at 12.5 mug/ml inhibited all bacteria tested. B. fragilis was resistant to both penicillin and carbenicillin at 6.2 mug/ml. Concentrations of 25 mug/ml for penicillin and 100 mug/ml for carbenicillin were needed to inhibit more than 90% of B. fragilis. Organisms other than B. fragilis were moderately or extremely susceptible to the penicillins.

MeSH Terms
Anti-Bacterial Agents/pharmacology Bacteria, Anaerobic/drug effects Carbenicillin/pharmacology Clindamycin/pharmacology Drug Resistance, Bacterial Humans Microbial Sensitivity Tests Minocycline/pharmacology
Chemicals
Anti-Bacterial Agents Clindamycin Minocycline Carbenicillin
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Staneck J L
Washington J A
References (27)
27 references, click to expand
  1. The susceptibility of bacteroides to the penicillins and cephalothin.
    Am J Med Sci. 1966 Apr;251(4):428-32 PMID: 5910227
  2. Antibiotic susceptibility testing of Bacteroides.
    Antimicrob Agents Chemother. 1972 Aug;2(2):57-60 PMID: 4670488
  3. Standardized antimicrobial disc susceptibility testing of anaerobic bacteria: in vitro susceptibility of Clostridium perfringens to nine antibiotics.
    Antimicrob Agents Chemother. 1972 Oct;2(4):320-5 PMID: 4363787
  4. Resistance of some species of Clostridium to clindamycin.
    Antimicrob Agents Chemother. 1973 Jan;3(1):136-7 PMID: 4790570
  5. Bacteriostatic and bactericidal activities of various antibiotics against Bacteroides fragilis.
    Antimicrob Agents Chemother. 1973 Feb;3(2):152-6 PMID: 4790582
  6. Susceptibility of Bacteroides fragilis to six antibiotics determined by standardized antimicrobial disc susceptibility testing.
    Antimicrob Agents Chemother. 1973 Feb;3(2):188-93 PMID: 4790586
  7. Treatment of anaerobic bacterial infections with clindamycin-2-phosphate.
    Antimicrob Agents Chemother. 1974 Mar;5(3):276-80 PMID: 4600161
  8. In vitro antimicrobial susceptibility of anaerobic bacteria isolated from clinical specimens.
    Antimicrob Agents Chemother. 1972 Feb;1(2):148-58 PMID: 4680804
  9. CLINICAL AND BACTERIOLOGIC STUDIES OF THE EFFECT OF "MASSIVE" DOSES OF PENICILLIN G ON INFECTIONS CAUSED BY GRAM-NEGATIVE BACILLI.
    N Engl J Med. 1964 Sep 10;271:525-33 PMID: 14172468
  10. Systemic treatment of human trichomoniasis with a derivative of nitro-imidazole, 8823 RP.
    Br J Vener Dis. 1960 Mar;36:21-6 PMID: 13818819
  11. Susceptibility of Clostridium ramosum to antimicrobial agents.
    Antimicrob Agents Chemother. 1974 Jun;5(6):589-93 PMID: 15825410
  12. A study in vitro of the sensitivity to antibiotics of Bacteroides fragilis.
    J Clin Pathol. 1968 Jul;21(4):432-6 PMID: 4301500
  13. Single and low dosage regimens of metronidazole in amoebic dysentery and amoebic liver abscess.
    Ann Trop Med Parasitol. 1969 Jun;63(2):139-42 PMID: 4313446
  14. Bacteremic Bacteroides infections.
    Ann Intern Med. 1970 Oct;73(4):537-44 PMID: 5506005
  15. Standardized antimicrobial disc susceptibility testing of anaerobic bacteria. I. Susceptibility of Bacteroides fragilis to tetracycline.
    Appl Microbiol. 1972 Feb;23(2):268-75 PMID: 5017675
  16. Bactericidal activity of five antimicrobial agents against Bacteroides fragilis.
    J Infect Dis. 1972 Jul;126(1):104-7 PMID: 5038022
  17. Anaerobic bacteremia.
    Mayo Clin Proc. 1972 Sep;47(9):639-46 PMID: 5073944
  18. Metronidazole versus anaerobes. In vitro data and initial clinical observations.
    Calif Med. 1972 Dec;117(6):22-6 PMID: 4635396
  19. Treatment of severe bacteroides infections with parenteral clindamycin.
    Can Med Assoc J. 1972 Dec 23;107(12):1177-81 PMID: 4638419
  20. Treatment of anaerobic infections with lincomycin and clindamycin.
    N Engl J Med. 1972 Nov 16;287(20):1006-10 PMID: 4346707
  21. Clindamycin in the treatment of serious anaerobic infections.
    Ann Intern Med. 1973 Jun;78(6):853-9 PMID: 4713566
  22. Bactericidal activity of metronidazole against Bacteroides fragilis.
    J Clin Pathol. 1973 Jun;26(6):393-5 PMID: 4718964
  23. Abdominal trauma, anaerobes, and antibiotics.
    Surg Gynecol Obstet. 1973 Aug;137(2):270-6 PMID: 4723349
  24. Treatment of Bacteroides fragilis bacteremia with clindamycin.
    J Infect Dis. 1973 Oct;128(4):569-71 PMID: 4743549
  25. Incidence and isolation of Bacteroides species from clinical material and their sensitivity to antibiotics.
    J Clin Pathol. 1973 Oct;26(10):738-41 PMID: 4584348
  26. The bacteriology of aspiration pneumonia.
    Am J Med. 1974 Feb;56(2):202-7 PMID: 4812076
  27. Metronidazole in human infections with syphilis.
    Br J Vener Dis. 1967 Sep;43(3):197-200 PMID: 6050885
Article Info
Journal
Antimicrobial agents and chemotherapy
Abbr.
Antimicrob Agents Chemother
ISSN
0066-4804
Published
1974-09-00
Pages
311-5
Language
English
Region
United States
NLM ID
0315061
PMCID
PMC444642
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]